The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation Study.
ADVANCES IN THERAPY（2024）
关键词
Bevacizumab,Biosimilars,Epoetin alfa,Filgrastim,Interchangeability,Oncology care model,Pegfilgrastim,Rituximab,Trastuzumab,Value-based care
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要